Daniel Klamer
Corporate Officer/Principal at ANAVEX LIFE SCIENCES CORP.
Network origin in Daniel Klamer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
Sahlgrenska University
6
| College/University | Other Consumer Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Klamer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Gothenburg | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| WHU-Otto Beisheim School of Management | College/University | Masters Business Admin Doctorate Degree | |
| ECTIN RESEARCH AB | Biotechnology | Founder Founder | |
| Karolinska Institutet | College/University | Director/Board Member Doctorate Degree | |
| Stayble AB | Director/Board Member | ||
| University of Bonn | College/University | Doctorate Degree | |
Puls AB
 Puls AB Environmental ServicesIndustrial Services Puls AB is a Swedish company that specializes in sewage, industrial, and environmental services. Puls is located in Staffanstorp, Sweden and is known as the largest player in va maintenance in southern Sweden. The private company offers on-call assistance for a range of issues, including emergency stops in the drain and remediation after accidents. The company provides services such as sewage cleaning, wastewater flushing, and water blasting to clean tanks, cisterns, sheet metal, boat hulls, and more in an environmentally friendly manner. The company has a team of talented employees who specialize in water and wastewater services for tenant-owner associations, offering maintenance and emergency measures. | Environmental Services | Corporate Officer/Principal | |
Hammars Bryggeri AB
 Hammars Bryggeri AB Beverages: AlcoholicConsumer Non-Durables Hammars Bryggeri AB engages in brewery operations. It produces a wide range of soft drinks, water, and other cider beverages. The company was founded in 1904 and is headquartered in Hammar, Sweden. | Beverages: Alcoholic | Director/Board Member | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chairman | |
Innoext AB
 Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Lidds Pharma AB | Corporate Officer/Principal | ||
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chairman | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Diaprost AB
 Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Sculptor Capital LP
 Sculptor Capital LP Investment ManagersFinance Sculptor Capital LP is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. Formerly known as OZ Management LP, the firm was founded by Daniel Och in 1994. They are directly owned by Calder Holdco I LP and indirectly owned by Rithm Capital Corp. (NYSE: RITM). Sculptor Capital provides portfolio management services to private funds, CLOs, and/or CBOs, as well as to SMAs for institutional clients, which may include financial institutions, public and private pension funds, sovereign wealth funds, endowments, and foundations. | Investment Managers | Analyst-Equity | |
| Innoex AB | Chief Executive Officer | ||
| Glactone Pharma Development AB | Chairman | ||
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LIDDS AB | Pharmaceuticals: Major | Chairman | |
BDO Canada LLP
 BDO Canada LLP Miscellaneous Commercial ServicesCommercial Services BDO Canada LLP provides accounting and advisory services. It also offers tax, assurance, bookkeeping, payroll, outsourcing, and consulting solutions and services. The company was founded by James M. Dunwoody in 1921 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| DESTINY MEDIA TECHNOLOGIES INC. | Packaged Software | Director of Finance/CFO | |
| University of Laurentian | College/University | Undergraduate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Epping Hermann Fischer Patentanwaltsgesellschaft mbH
 Epping Hermann Fischer Patentanwaltsgesellschaft mbH Miscellaneous Commercial ServicesCommercial Services Epping Hermann Fischer Patentanwaltsgesellschaft mbH provides expertise in all fields of technology and specialist areas of industrial property rights. Its services include patents and utility models, trademark, designs, portfolio strategies and management, domains, infringements and licensing matters services. The company was founded by Uwe Hermann in 1999 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Pharmaceuticals: Major | Director/Board Member | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| Clay Merger Sub II, Inc. | Director/Board Member | ||
Favus Institutional Research LLC
 Favus Institutional Research LLC Investment ManagersFinance Favus Institutional Research LLC is an independent equity investment research firm headquartered in New York City. The firm was founded by Dr. Elliot Favus in 2009. Favus Institutional Research focuses exclusively on providing healthcare equity research to institutional investors. They use fundamental analysis to evaluate the healthcare sector, with a focus on commercial, clinical data, legal, reimbursement, and regulatory catalysts. | Investment Managers | Chief Executive Officer | |
| CURIS, INC. | Biotechnology | Director of Finance/CFO | |
| Avaant Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
NetCologne Gesellschaft für Telekommunikation mbH
 NetCologne Gesellschaft für Telekommunikation mbH Specialty TelecommunicationsCommunications NetCologne Gesellschaft für Telekommunikation mbH provides telecommunication services. It operates self network telecommunications and provides services in all areas of communications like voice, data and internet. The company was founded on October 31, 1994 and is headquartered in Cologne, Germany. | Specialty Telecommunications | Chief Executive Officer | |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Pharmaceuticals: Major | General Counsel | |
| APRENDERE SKOLOR AB | Other Consumer Services | Director/Board Member | |
| Medlys HB | Corporate Officer/Principal | ||
Ivarsson Medical Research AB
 Ivarsson Medical Research AB Investment Banks/BrokersFinance Ivarsson Medical Research AB is a Swedish company that engages in the management and trading of securities. The CEO of the private company is Marie-Lois Ivarsson. | Investment Banks/Brokers | Chief Executive Officer | |
| University of Glasgow | College/University | Doctorate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Greenwood Genetic Center, Inc. | Corporate Officer/Principal | ||
| ELEVAI LABS INC. | Biotechnology | Director/Board Member | |
| University of the Fraser Valley | College/University | Undergraduate Degree |
Statistics
International
| Sweden | 23 |
| United States | 15 |
| Germany | 7 |
| Canada | 5 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 6 |
| Industrial Services | 2 |
Operational
| Director/Board Member | 57 |
| Corporate Officer/Principal | 38 |
| Chairman | 23 |
| Independent Dir/Board Member | 18 |
| Chief Executive Officer | 14 |
Most connected contacts
- Stock Market
- Insiders
- Daniel Klamer
- Company connections
